{"id":"NCT01718873","sponsor":"National Cancer Institute, Naples","briefTitle":"Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer","officialTitle":"Randomized Phase 3 Study on the Optimization of Bevacizumab With mFOLFOX/mOXXEL in the Treatment of Patients With Metastatic Colorectal Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05","primaryCompletion":"2015-12","completion":"2019-12","firstPosted":"2012-10-31","resultsPosted":"2023-04-12","lastUpdate":"2023-04-12"},"enrollment":230,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Colorectal Cancer"],"interventions":[{"type":"DRUG","name":"Bevacizumab","otherNames":["Avastin"]},{"type":"DRUG","name":"Oxaliplatin","otherNames":["Eloxatin"]},{"type":"DRUG","name":"levo-folinic acid","otherNames":["Lederfolin"]},{"type":"DRUG","name":"5-fluorouracil","otherNames":["Fluorouracil"]},{"type":"DRUG","name":"Capecitabine","otherNames":["Xeloda"]}],"arms":[{"label":"bevacizumab before chemotherapy","type":"EXPERIMENTAL"},{"label":"bevacizumab with chemotherapy","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate if giving bevacizumab prior to chemotherapy compared to giving bevacizumab at the same time as chemotherapy improves patient overall response to treatment.","primaryOutcome":{"measure":"Objective Response Rate","timeFrame":"Objective response was assessed by computed tomographic scan or other appropriate imaging at weeks 12 and 24 from randomization, and every 3 months thereafter, assessed up to 90 months.","effectByArm":[{"arm":"Bevacizumab Before Chemotherapy","deltaMin":65,"sd":null},{"arm":"Bevacizumab With Chemotherapy","deltaMin":66,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":19},"locations":{"siteCount":1,"countries":["Italy"]},"refs":{"pmids":["34309665","26857924"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":65,"n":115},"commonTop":["Peripheral neuropathy","Nausea","Neutrophil count decreased","Diarrhea","White blood cell count decreased"]}}